Jacobs Levy Equity Management’s MiMedx Group MDXG Stock Holding History

Jacobs Levy Equity Management’s Portfolio MDXG Stock Details MDXG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-30,516	Closed	-$186K	–	1052
2025 Q2	$186K	Hold	30,516	–	–	﹤0.01%	991
2025 Q1	$232K	Buy	+30,516	New	+$255K	﹤0.01%	1011
2023 Q2	–	Sell	-30,168	Closed	-$103K	–	1037
2023 Q1	$103K	Sell	30,168 -278,798	-90%	-$1.08M	﹤0.01%	934
2022 Q4	$859K	Sell	308,966 -220,039	-42%	-$658K	0.01%	703
2022 Q3	$1.52M	Buy	529,005 +218,554	+70%	+$777K	0.01%	613
2022 Q2	$1.08M	Sell	310,451 -156,859	-34%	-$614K	0.01%	738
2022 Q1	$2.2M	Buy	467,310 +121,082	+35%	+$592K	0.01%	604
2021 Q4	$2.09M	Buy	+346,228	New	+$2.4M	0.01%	613
2014 Q3	–	Sell	-21,600	Closed	-$153K	–	879
2014 Q2	$153K	Hold	21,600	–	–	﹤0.01%	775
2014 Q1	$132K	Buy	+21,600	New	+$159K	﹤0.01%	843

Other funds holding MDXG

EWM

Essex Woodlands Management The Woodlands, Texas $251M AUM 13.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Trigran Investments Northbrook, Illinois $418M AUM 3.34% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

PCMI

Paradigm Capital Management Inc Albany, New York $2.61B AUM 78.58% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Cannell Capital Alta, Wyoming $163M AUM 40.62% 1-Year Est. Return

Jacobs Levy Equity Management's MDXG Position: Q3 2025 in Review

Jacobs Levy Equity Management sold out of MiMedx Group (MDXG) in Q3 2025, closing a stake of 30,516 shares — an estimated $186K sold.

Jacobs Levy Equity Management first reported a position in MDXG in Q1 2014 and held it in 10 quarters. The position peaked at $2.2M in Q1 2022. 231 funds tracked by Wall St. Rank hold MDXG as of Q3 2025.

Jacobs Levy Equity Management reported no remaining MiMedx Group position as of Q3 2025 after selling out during the quarter.
Jacobs Levy Equity Management sold 30,516 MiMedx Group shares in Q3 2025, an estimated $186K.
Jacobs Levy Equity Management first reported a position in MiMedx Group in Q1 2014 and held it in 10 quarters.
Jacobs Levy Equity Management's MiMedx Group position peaked at $2.2M in Q1 2022.
231 funds tracked by Wall St. Rank held MiMedx Group as of Q3 2025.

Based on Jacobs Levy Equity Management's 13F filing for Q3 2025, filed 17 Nov 2025.